GlobeNewsWire
26 May 2026, 20:44 UTC · 2h ago
Source · https://www.globenewswire.com/news-release/2026/05/26/3301496/0/en/NANOBIOTIX-Announces-Closing-of-Global-Offering.html
Read source
Search tags
Story key points
3 claims · impact-rated
The company believes the net proceeds and existing cash will cover working capital requirements into 2029. — Extending the cash runway by several years significantly reduces the immediate risk of bankruptcy or further dilutive funding rounds.
+0.50Nanobiotix closed a global offering that raised approximately $100 million in gross proceeds. — A significant capital infusion provides the company with essential liquidity to fund its late-clinical stage operations.
+0.40The offering included the issuance of over 2.2 million ordinary shares and pre-funded warrants, priced at a 14.92% discount to the recent volume-weighted average price. — The issuance of a large volume of new shares at a discount causes immediate equity dilution for existing shareholders.
-0.30Impact vectors
3 dimensions · 9 clusters
Market reaction
10 bid · 10 offered
Ticker attribution
Model heads
The company successfully closed a global offering raising approximately $100 million, extending its cash runway into 2029.
The company successfully closed a global offering raising approximately $100 million, extending its cash runway into 2029.
